IGF-1R inhibition induced activation of Yes/SFK acts as a by-pass resistance pathway in rhabdomyosarcoma

被引：0
|
作者：
Wan, X. [1 ]
Yeung, C. [1 ]
Heske, C. [1 ]
Mendoza, A. [1 ]
HIman, L. J. [1 ]
机构：
[1] NCI, Pediat Oncol Branch, Bethesda, MD 20892 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)70437-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
311
引用
收藏
页码：101 / 101
页数：1
相关论文
共 50 条
  • [1] IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma
    Wan, Xiaolin
    Yeung, Choh
    Heske, Christine
    Mendoza, Arnulfo
    Helman, Lee J.
    NEOPLASIA, 2015, 17 (04): : 358 - 366
  • [2] IGF-IR inhibition effect on a yes/SFK bypass resistance pathway: Rational basis for cotargeting IGF-IR and yes/SFK kinase in rhabdomyosarcoma.
    Wan, Xiaolin
    Yeung, Choh
    Heske, Christine
    Mendoza, Arnulfo
    Helman, Lee J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Sensitivity and resistance to cell cycle and IGF-1R inhibitors in rhabdomyosarcoma
    Montoya, Justin
    Lee, David W.
    Aleem, Eiman
    CANCER RESEARCH, 2017, 77
  • [4] The Role of PDGFR-β Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma
    Heske, Christine M.
    Yeung, Choh
    Mendoza, Arnulfo
    Baumgart, Joshua T.
    Edessa, Leah D.
    Wan, Xiaolin
    Helman, Lee J.
    TRANSLATIONAL ONCOLOGY, 2016, 9 (06): : 540 - 547
  • [5] IGF-1R inhibition: right direction, wrong pathway?
    Wilson, Sheridan
    Chia, Stephen K.
    LANCET ONCOLOGY, 2013, 14 (03): : 182 - 183
  • [6] Histone deacetylase inhibition triggers suppression of the IGF-1R/Akt pathway in rhabdomyosarcoma and Pax3-Foxo1 in alveolar rhabdomyosarcoma
    Wan, X.
    Issak, S.
    Yeung, C.
    McCalla, A.
    Helman, L.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S40 - S40
  • [7] Role of IGF-1R inhibition on an Src-family kinase bypass resistance pathway: A rational basis for cotargeting IGF-1R and Src kinase in pediatric sarcomas?
    Wan, Xiaolin
    Yeung, Choh L.
    Heske, Christine
    Mendoza, Arnulfo
    Helman, Lee J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Gefitinib resistance in HCC mahlavu cells: Upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation
    Bodzin, Adam S.
    Wei, Zhengyu
    Hurtt, Reginald
    Gu, Tina
    Doria, Cataldo
    JOURNAL OF CELLULAR PHYSIOLOGY, 2012, 227 (07) : 2947 - 2952
  • [9] CXCL14 Maintains hESC Self-Renewal through Binding to IGF-1R and Activation of the IGF-1R Pathway
    Cheng, Chih-Lun
    Yang, Shang-Chih
    Lai, Chien-Ying
    Wang, Cheng-Kai
    Chang, Ching-Fang
    Lin, Chun-Yu
    Chen, Wei-Ju
    Lin, Po-Yu
    Wu, Han-Chung
    Ma, Nianhan
    Lu, Frank Leigh
    Lu, Jean
    CELLS, 2020, 9 (07) : 1 - 20
  • [10] Study on activation of the IGF-1R mTOR pathway in neuroendocrine tumours (NETs)
    Casanovas, Oriol
    Teule, Alex
    Villabona, Carles
    Serrano, Teresa
    Fabregat, Joan
    Salazar, Ramon
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345